Full-Time

Software Engineer I

EMES Recipe Author

Confirmed live in the last 24 hours

Deadline 8/3/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Junior

Hyderabad, Telangana, India

In Person

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree in engineering, Computer Science or related fields.
  • 1 to 2 years of experience in software development.
  • Experience in Emerson Syncade/WerumPasX
  • Good Understanding of SDLC (Software Development Life Cycle).
  • Experience using or configuring Manufacturing Execution Systems is a huge plus.
  • Experience in the Life Sciences industry or in a regulated manufacturing environment is a plus.
  • Good understanding of the application of IT to manufacturing, including a broad understanding of processes and how they are supported by IT tools and systems is a plus.
  • Knowledge of regulatory landscape and experience with software validation is a plus.
  • Ability to work across global sites and cultures.
  • Ability to effectively communicate with both technical and non-technical team members.
  • Good written and verbal communication skills.
  • Knowledge of cGMP regulations.
  • Ability to provide on-call support.
  • Ability to interpret / write technical documents.
  • Ability to work as a team.
  • Quick Learner.
Responsibilities
  • Support global recipe management strategy to maximize reuse of recipes and/or recipe segments across sites
  • Build recipes that are designed around simplicity, flexibility, and cost effectiveness
  • Partner with MS&T and Process Robustness team to configure recipes in support of analytics
  • Contribute in recipe delivery process including partnering with Supply Chain, MS&T, Quality, and Manufacturing Operations to understand business requirements
  • Recipe authoring, demos and dry run facilitation
  • Recipe User Acceptance Testing
  • Recipe and master data installations and promotions
  • Ensure recipes are built with consistency and adhere to guidelines
  • Perform recipe and specification review and approvals
  • Gather and manage requirements around batch reports that relate to the Review by Exception and Release by Exception strategies
  • Tier 3 escalation support of recipes and process to minimize disruption to manufacturing and/or impact to product
  • Support strategy for collecting end user feedback and improving the usability and user experience of the overall EMES solution
  • Support risk and impact assessment that changes, patches, outages or other events can have to the EMES solution and the global network and define mitigation strategies
  • Support a knowledge management strategy including generating training content
  • Promote compliance with data integrity and computer system validation requirements and regulations
  • Promote compliance by understanding change and the impact to the validated state of the application and underlying infrastructure.
Desired Qualifications
  • Experience in the Life Sciences industry or in a regulated manufacturing environment is a plus.
  • Good understanding of the application of IT to manufacturing, including a broad understanding of processes and how they are supported by IT tools and systems is a plus.
  • Knowledge of regulatory landscape and experience with software validation is a plus.

Bristol Myers Squibb (BMS) is a biopharmaceutical company that develops and delivers medicines for serious diseases, focusing on oncology, immunology, and cardiovascular conditions. The company invests heavily in research and development to create new drugs, which are sold to hospitals and healthcare providers after receiving regulatory approval. BMS also produces affordable generic drugs and supports the development of biosimilars, ensuring they meet safety and efficacy standards. With a commitment to sustainability and corporate responsibility, BMS aims to improve patient outcomes and increase access to healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Chris Shibutani's appointment may drive strategic growth and innovation at BMS.
  • Advancements in targeted protein degradation enhance therapeutic offerings in oncology.
  • Partnership with BioNTech could provide a competitive edge against Merck's Keytruda.

What critics are saying

  • Antitrust litigation over Pomalyst could impact BMS's market position in oncology.
  • Reliance on real-world data presents challenges in data quality and implementation.
  • High costs and technical challenges in space research could affect treatment feasibility.

What makes Bristol Myers Squibb unique

  • BMS collaborates with BioNTech for next-gen cancer immunotherapy, enhancing oncology portfolio.
  • Focus on real-world data strategies could lead to faster drug market entry.
  • Developing bone disease treatments in space positions BMS as a leader in innovative research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

ISS National Lab
Jul 7th, 2025
This is Not the Time to Cut Space-enabled Medical Research

Bristol-Myers Squibb is developing novel bone disease treatments in space, and the National Stem Cell Foundation is studying 3D brain organoids derived from patients with Parkinson's disease in microgravity to observe disease progression more rapidly with the aim of identifying potential biomarkers for early diagnosis and therapeutic targets.

The Pharma Letter
Jun 26th, 2025
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst

Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst.

Unlearn
Jun 24th, 2025
The Best 15 Minutes You'll Spend on Clinical Trials Today

At the 2025 "Digital Breakthrough for Pharma" Summit hosted by Bristol Myers Squibb, Unlearn's co-founder and machine learning scientist, Aaron Smith, took the stage to explain exactly how that vision is now a reality.

ROI-NJ
Jun 13th, 2025
Bristol Myers Squibb Names Shibutani As Evp, Chief Strategy Officer

Bristol Myers Squibb (BMS) this week appointed Chris Shibutani as executive vice president, chief strategy officer, effective immediately. Shibutani’s role is a new position on the BMS leadership team. The announcement was made on a LinkedIn post.Shibutani will lead the development and advancement of the company’s long-term strategic plan, collaborating across the enterprise to drive innovation and growth. He brings more than 25 years of experience in the financial services industry covering global pharmaceutical, biotechnology and medical device industries.Prior to BMS, Shibutani served as managing director in the global investment research division at Goldman Sachs. Previous roles include senior analyst positions at Hambrecht & Quist, Cowen, UBS, and J.P. Morgan.Before his career in finance, Shibutani was a physician trained in anesthesiology and critical care medicine at Massachusetts General Hospital and practiced at Memorial Sloan Kettering Cancer Center

PharmaData
Jun 13th, 2025
Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

Bristol Myers Squibb highlights targeted protein degradation advances, including CELMoD agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy.